Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)

Clinical Rheumatology

Volumn 24, Issue 1, 2005, Pages 3-10

  Georges, Claire ^a   Chassany, O ^a   Mouthon, L ^b   Tiev, K ^c   Toledano, C ^a   Meyer, O ^d   Marjanovic, Z ^a   Heneggar, C ^a   Papo, T ^d   Crickx, B ^d   Sereni, D ^a   Cabane, J ^c   Farge, D ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

Functional repercussion; Health Assessment Questionnaire; Scleroderma; Systemic sclerosis

Indexed keywords

ACCURACY; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFUSE SCLERODERMA; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; FEMALE; FRANCE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SCLERODERMA; SCORING SYSTEM; SELF EVALUATION; SHORT FORM 36; SYSTEMIC SCLEROSIS; VALIDATION PROCESS; VISUAL ANALOG SCALE;

DISABILITY EVALUATION; FEMALE; FRANCE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TRANSLATIONS;

EID: 20844454516     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0942-3     Document Type: Article

References (20)

1. Poole JL, Steno VD (1991) The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4:27-31 1:STN:280:DC%2BD3M7jslygtA%3D%3D
2. Steen VD, Medsger TA (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40:1984-1991 1:STN:280:DyaK1c%2FjtVeluw%3D%3D
3. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N, for the European Regulatory Issues on Quality of Life Assessment (ERIQA) group (2002) Patient-reported outcomes: The example of Health-Related Quality of Life - a European guidance document for the improved integration of health-related quality of life assessment in the drug approval process. Drug Inf J 36:209-238
4. Gandek B, Ware JE Jr, Aaronson NK, Alonso J, Apolone G, Bjorner JB, et al. (1998) Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA project. J Clin Epidemiol 51:1149-1158 10.1016/S0895-4356(98)00106-1
5. Scientific Advisory Committee of the Medical Outcome Trust (2002) Assessing health status and quality of life instruments: Attributes and review criteria. QOL Res 11:193-205
6. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early sclerosis. J Rheumatol 28:1573-1576 1:STN:280:DC%2BD38%2Fit1Oqsw%3D%3D
7. Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9:789-793 1:STN:280:BiyD1crlvFE%3D
8. Guillemin F, Briançon S, Pourel J (1991) Mesure de la capacité fonctionnelle dans la polyarthrite rhumatoïde: adaptation française du Health Assessment Questionnaire (HAQ). Rev Rhum 58:459-465 1:STN:280:By6A2snls1E%3D
9. Acquadro C, Jambon B, Ellis D, Marquis P (1996) Language and translation issues. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadelphia, pp 575-585
10. Ware JE Jr (1993) SF-36 Health Survey: Manual and interpretation guide. Health Institute, New England Medical Center, Boston
11. Leplege A, Ecosse E, Verdier A, Perneger TV (1998) The French SF-36 Health Survey: Translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51:1013-1023 10.1016/S0895-4356(98)00093-6
12. Medsger T, Silman A, Steen V, Black C, Akesson A, Bacon P, et al. (1999) A disease severity scale for systemic sclerosis: Development and testing. J Rheumatol 26:2159-2167 10529133
13. Clements PH, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. (1995) Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281-1285 1:STN:280:BymD2MjivVc%3D
14. Lohr KN, Aaronson NK, Alonso J, Burnam MA, Patrick DL, Perrin EB, et al. (1996) Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 18:979-992 10.1016/S0149-2918(96)80054-3
15. Guyatt GH, Kirshner B, Jaeschke R (1992) Measuring health status: What are the necessary measurement properties? J Clin Epidemiol 45:1341-1345 10.1016/0895-4356(92)90194-R
16. Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, Fraitag B, et al. (1999) Validation of a specific quality of life questionnaire in functional digestive disorders (FDDQL). Gut 44:527-533 1:STN:280:DyaK1M7nslajsQ%3D%3D
17. Guillevin L, Ortonne JP (1983) Traitement de la sclérodermie. Ann Med Interne 34:754-765
18. Ruof J, Bruhlmann P, Michel BA, Stucki G (1999) Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). Rheumatology 38:535-542 10.1093/rheumatology/38.6.535
19. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44:653-661 10.1002/1529-0131(200103)44:3<653::AID-ANR114>3.3.CO;2-H
20. Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, et al. (2002) Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis. Br J Haematol 119:729-739 10.1046/j.1365-2141.2002.03895.x